arrow
Α

Αngelos Koutras

general university hospital of patras
H指数:35
被引数:4,045

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-World Neoadjuvant Systemic Therapy Utilization and Treatment Patterns in Patients with Early-Stage or Locally Advanced Triple-Negative Breast Cancer in Greece—The TRINITY Study

真实世界中希腊早期或局部晚期三阴性乳腺癌患者新辅助全身治疗的应用及治疗模式—TRINITY研究

2025-12-170
OAAI
Real-world safety and efficacy of trastuzumab deruxtecan (T-DXd) in patients with HER2-positive/HER2-low metastatic breast cancer: a multicenter retrospective cohort study

曲妥珠单抗德鲁替康(T-DXd)在HER2阳性/HER2低表达转移性乳腺癌患者中的真实世界安全性与有效性:一项多中心回顾性队列研究

2025-09-140
PRE
Integrative analysis of circulating tumor cells (CTCs) and exosomes from small-cell lung cancer (SCLC) patients: a comprehensive approach
2024-11-220
OAAI
Implementing geriatric assessment for dose optimization of CDK4/6 inhibitors in older breast cancer patients
2024-10-211
OAAI
Real-world data on the safety and efficacy of trastuzumab deruxtecan and sacituzumab govitecan in patients with advanced breast cancer: the experience of the Hellenic Cooperative Oncology Group
2024-03-010
PRE
Ten-year clinical outcome, toxicity and compliance of dose-dense sequential adjuvant administration of cyclophosphamide & epirubicin followed by docetaxel in patients with early breast cancer: A hellenic cooperative oncology group observational study (HE 10/10) with concurrent investigation of significance of tumor infiltrating lymphocytes

早期乳腺癌患者采用环磷酰胺与表柔比星序贯、密集给药,随后序贯多西他赛辅助治疗的十年临床疗效、毒性和依从性:一项由希腊肿瘤协作组开展的观察性研究(HE 10/10),并同步探讨肿瘤浸润淋巴细胞的临床意义

BREAST
IF7.9
2024-02-014
OAAI
Clinical and molecular study with digital support of advanced non-small cell lung cancer patients: SNF-CLIMEDIN, a prospective randomized Hellenic Cooperative Oncology Group (HeCOG) study: Interim analysis

晚期非小细胞肺癌患者数字支持的临床和分子研究: snf-climedin,一项前瞻性随机希腊肿瘤协作组 (HeCOG) 研究: 中期分析

2023-10-011
OAAI
Myo1e overexpression in lung adenocarcinoma is associated with increased risk of mortality
2023-03-133
OAAI
Validation of Patras Immunotherapy Score model for prediction and prognosis of patients with advanced NSCLC treated with nivolumab or pembrolizumab: results from a European multicentre study

Patras免疫治疗评分模型对nivolumab或pembrolizumab治疗晚期NSCLC患者的预测和预后的验证: 来自欧洲多中心研究的结果

2022-09-081
OAAI
Dose-dense sequential adjuvant chemotherapy in the trastuzumab era: final long-term results of the Hellenic Cooperative Oncology Group Phase III HE10/05 Trial

曲妥珠单抗时代的剂量密集序贯辅助化疗: 希腊肿瘤协作组HE10/05 III期试验的最终长期结果

2022-05-242
OA
Dose-dense sequential adjuvant chemotherapy in the trastuzumab era: Final long-term results of the hellenic cooperative oncology group phase III HE10/05 trial

曲妥珠单抗时代的剂量密集序贯辅助化疗: 希腊肿瘤协作组HE10/05 III期试验的最终长期结果

2022-02-150
PRE